Adicet Bio Inc ADI-001 Interim Clinical Data Call Transcript
Good morning, everyone, and welcome to Adicet Specially scheduled conference call. This call is being recorded.
(Operator Instructions)
I would now like to turn the call over to (inaudible). Please go ahead.
Thank you. On the call today from Adicet are Chen Schor, President and CEO; Dr. Francesco Galimi, Chief Medical Officer; Nick Harvey, Chief Financial Officer; and Dr. Blake Aftab, Chief Scientific Officer.
In addition, we're pleased to have Dr. Sattva Neelapu, professor in the Department of Lymphoma and Myeloma at the MD Anderson Cancer Center joining us today. We'll start the presentation with an introductory remarks by Chen, and then Francesco will review the interim results in more detail. Dr. Neelapu will then provide his thoughts on the data and speak to the potential opportunities offered by gamma delta CAR T cell therapy. After that, we'll open up the call for Q&A.
But before we begin, I'd like to remind you that various remarks that we make on this call contain forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
